Mid-size scale Raritan Pharmaceuticals operates with 51-200 employees and reported annual revenue between $50M and $100M, suggesting a mid-market size suitable for strategic partnerships, contract manufacturing, or value-added services targeting mid-tier pharma players.

Technology stack The company relies on common web and enterprise technologies (WordPress, MySQL, ASP.NET, IIS, Nginx) which can inform potential digital security and hosting services, cloud optimization, and compliance enhancements for their online presence and customer portals.

Growth signals With a modest but solid revenue band and the presence of established industry peers in the same market, there is potential for product line expansion, licensing, or collaboration in generic or specialty pharma segments.

Operational location Headquartered in East Brunswick, NJ, potential sales conversations can leverage the Northeast manufacturing and biotech cluster dynamics, including regional partnerships, regulatory affairs support, and local supply-chain optimization.

Competitive context Comparative peers are significantly larger; this positions Raritan as a target for services that improve margins and scale operations, such as contract manufacturing optimization, quality systems modernization, regulatory consulting, and strategic licensing deals.